调脂治疗的靶点：LDL、非高密度脂蛋白胆固醇，还是HDL ？
Lipid Target: LDL, Non? High-Density Lipoprotein Cholesterol, or HDL?
调脂增寿汤与普伐他汀片均可有效降低动脉硬化指数及非高密度脂蛋白胆固醇；
The level of HDLc were significantly increased and the levels of ApoBioo and Hey were significantly decreased in Tiaozhi Zengshou Decoction group.
目的探讨体检人群高尿酸血症与血致动脉硬化指数、非高密度脂蛋白胆固醇水平相关性及意义。
Objective To analyze the correlation between hyperuricemia and non-high density lipoprotein cholesterol and atherogenic index of plasma in a normal population.
研究者指出，在过去10年期间至少有一次调查，有34.2%患者总胆固醇曾升高，9.4%高密度脂蛋白降低和47.8%非高密度脂蛋白升高。
On at least one visit during the 10-year period, 34.2% had elevated total cholesterol, 9.4% had low HDL, and 47.8% had elevated non-HDL, the researchers note.
研究者指出，在过去10年期间至少有一次调查，有34.2%患者总胆固醇曾升高，9.4%高密度脂蛋白降低和47.8%非高密度脂蛋白升高。
On at least one visit during the 10-year period, 34.2% had elevated total cholesterol, 9.4% had low HDL, and 47.8% had elevated non-HDL, the researchers note.
应用推荐